(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged самостоятелно, бяха сравнени с тези на плацебо (сляпо лечение).
(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Το Riprazo µελετήθηκε σε 14 κύριες µελέτες, στις οποίες µετείχαν περισσότεροι από 10. 000 ασθενείς µε ιδιοπαθή υπέρταση.